Imaging Biomarkers in ALS

Part of paid clinical trials in Minneapolis, Minnesota.

Sponsor
University of Minnesota
Study ID
NCT02567136
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
21 Years - 75 Years
Healthy Volunteers
Accepted

Study Details

The purpose of the study is to determine if we are able to find one or more biomarkers of Amyotrophic Lateral Sclerosis (ALS) and Primary Lateral Sclerosis (PLS) using magnetic resonance imaging (MRI) scans at different levels, 3 tesla (3T) and 7 tesla (7T). A biomarker is a measurable characteristic that can be used as an indicator of a particular disease state. Identifying biomarkers of a disease can lead to a better understanding of the disease as well as improved treatments. This study will enroll patients with ALS, PLS, and healthy controls.

Key Dates

Start date
Sep 30, 2015
Status verified
Nov 2025
Primary completion
Sep 30, 2030
Completion
Sep 30, 2031

Study Design

Enrollment
30 participants (estimated)

Arms

  • Arm: Amyotrophic Lateral Sclerosis
    Patients with ALS
  • Arm: Healthy Controls
    Healthy control volunteers

Primary Outcome Measure

Imaging biomarkers [ Time Frame: 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of MinnesotaMinneapolisMinnesota55414
Valerie Ferment
[email protected]
612-301-1535
David Walk, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Minneapolis, MN

By research site
University of Minnesota· Minneapolis, MN

Related Studies